Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

8-Azaadenosine is a purine nucleoside analog and an inhibitor of adenosine deaminase acting on RNA 1 (ADAR1), an enzyme that converts adenosine to inosine in dsRNA, a post-transcriptional modification known as A-to-I editing.1 It inhibits RNA A-to-I editing in, as well as the invasion and migration of, TPC-1 and Cal-62 thyroid cancer cells when used at concentrations of 1 and 2 µM. 8-Azaadenosine (2 mg/kg) increases the ex vivo secretion of IFN-γ and TNF-α from CD8+ T cells isolated from mouse spleen in a model of hepatitis B virus (HBV) infection.2 It decreases serum levels of HBV surface antigen (HBsAg) in the same model.
WARNING This product is not for human or veterinary use.
1. ADAR1-
2. Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-